Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 239

1.

Prevalence and incidence of bronchiectasis in Italy.

Aliberti S, Sotgiu G, Lapi F, Gramegna A, Cricelli C, Blasi F.

BMC Pulm Med. 2020 Jan 16;20(1):15. doi: 10.1186/s12890-020-1050-0.

2.

Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST).

Artaraz A, Crichton ML, Finch S, Abo-Leyah H, Goeminne P, Aliberti S, Fardon T, Chalmers JD.

Respir Res. 2020 Jan 13;21(1):18. doi: 10.1186/s12931-019-1272-y.

3.

Response to eribulin in a patient with metastatic uterine leiomyosarcoma: a case report.

Aliberti S, Miano S, Tolomeo F, Merlini A, Aglietta M, Grignani G.

Future Oncol. 2020 Jan;16(1s):15-19. doi: 10.2217/fon-2019-0597. Epub 2020 Jan 9.

PMID:
31916842
4.

Continuous professional development: elevating thoracic oncology education in Europe.

van Geffen WH, Blum TG, Aliberti S, Blyth KG, Bostantzoglou C, Farr A, Grigoriu B, Hardavella G, Huber RM, Maskell N, Massard G, Rahman NM, Stolz D, van Meerbeeck J.

Breathe (Sheff). 2019 Dec;15(4):279-285. doi: 10.1183/20734735.0296-2019.

5.

The biology of pulmonary exacerbations in bronchiectasis.

Amati F, Simonetta E, Gramegna A, Tarsia P, Contarini M, Blasi F, Aliberti S.

Eur Respir Rev. 2019 Nov 20;28(154). pii: 190055. doi: 10.1183/16000617.0055-2019. Print 2019 Dec 31.

6.

Evaluation of active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients: A comparison among different techniques.

Oriano M, Terranova L, Sotgiu G, Saderi L, Bellofiore A, Retucci M, Marotta C, Gramegna A, Miglietta D, Carnini C, Marchisio P, Chalmers JD, Aliberti S, Blasi F.

Pulm Pharmacol Ther. 2019 Dec;59:101856. doi: 10.1016/j.pupt.2019.101856. Epub 2019 Oct 15.

PMID:
31626976
7.

QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis.

Sotgiu G, Saderi L, Petruccioli E, Aliberti S, Piana A, Petrone L, Goletti D.

J Infect. 2019 Nov;79(5):444-453. doi: 10.1016/j.jinf.2019.08.018. Epub 2019 Aug 29.

PMID:
31473271
8.

Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry.

Dhar R, Singh S, Talwar D, Mohan M, Tripathi SK, Swarnakar R, Trivedi S, Rajagopala S, D'Souza G, Padmanabhan A, Baburao A, Mahesh PA, Ghewade B, Nair G, Jindal A, Jayadevappa GDH, Sawhney H, Sarmah KR, Saha K, Anantharaj S, Khanna A, Gami S, Shah A, Shah A, Dutt N, Garg H, Vyas S, Venugopal K, Prasad R, Aleemuddin NM, Karmakar S, Singh V, Jindal SK, Sharma S, Prajapat D, Chandrashekaria S, McDonnell MJ, Mishra A, Rutherford R, Ramanathan RP, Goeminne PC, Vasudev P, Dimakou K, Crichton ML, Jayaraj BS, Kungwani R, Das A, Sawhney M, Polverino E, Torres A, Gulecha NS, Shteinberg M, De Soyza A, Mangala A, Shah P, Chauhan NK, Jajodia N, Singhal A, Batra S, Hasan A, Limaye S, Salvi S, Aliberti S, Chalmers JD.

Lancet Glob Health. 2019 Sep;7(9):e1269-e1279. doi: 10.1016/S2214-109X(19)30327-4. Erratum in: Lancet Glob Health. 2019 Dec;7(12):e1621.

9.

Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia.

Villafuerte D, Aliberti S, Soni NJ, Faverio P, Marcos PJ, Wunderink RG, Rodriguez A, Sibila O, Sanz F, Martin-Loeches I, Menzella F, Reyes LF, Jankovic M, Spielmanns M, Restrepo MI; GLIMP Investigators.

Respirology. 2019 Aug 5. doi: 10.1111/resp.13663. [Epub ahead of print]

PMID:
31385399
10.

In Vitro Synergism of Colistin and N-acetylcysteine against Stenotrophomonas maltophilia.

Ciacci N, Boncompagni S, Valzano F, Cariani L, Aliberti S, Blasi F, Pollini S, Rossolini GM, Pallecchi L.

Antibiotics (Basel). 2019 Jul 25;8(3). pii: E101. doi: 10.3390/antibiotics8030101.

11.

Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria.

Capsoni N, Bellone P, Aliberti S, Sotgiu G, Pavanello D, Visintin B, Callisto E, Saderi L, Soldini D, Lardera L, Monzani V, Brambilla AM.

Multidiscip Respir Med. 2019 Jul 5;14:23. doi: 10.1186/s40248-019-0185-4. eCollection 2019.

12.

International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia.

Aliberti S, Cook GS, Babu BL, Reyes LF, H Rodriguez A, Sanz F, Soni NJ, Anzueto A, Faverio P, Sadud RF, Muhammad I, Prat C, Vendrell E, Neves J, Kaimakamis E, Feneley A, Swarnakar R, Franzetti F, Carugati M, Morosi M, Monge E, Restrepo MI; GLIMP investigators.

J Infect. 2019 Oct;79(4):300-311. doi: 10.1016/j.jinf.2019.07.004. Epub 2019 Jul 9.

PMID:
31299410
13.

Antimicrobial peptides, disease severity and exacerbations in bronchiectasis.

Sibila O, Perea L, Cantó E, Shoemark A, Cassidy D, Smith AH, Suarez-Cuartin G, Rodrigo-Troyano A, Keir HR, Oriano M, Ong S, Vidal S, Blasi F, Aliberti S, Chalmers JD.

Thorax. 2019 Sep;74(9):835-842. doi: 10.1136/thoraxjnl-2018-212895. Epub 2019 Jul 5.

PMID:
31278172
14.

Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients.

Di Pasquale MF, Sotgiu G, Gramegna A, Radovanovic D, Terraneo S, Reyes LF, Rupp J, González Del Castillo J, Blasi F, Aliberti S, Restrepo MI; GLIMP Investigators .

Clin Infect Dis. 2019 Apr 24;68(9):1482-1493. doi: 10.1093/cid/ciy723.

15.

A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation.

Shoemark A, Cant E, Carreto L, Smith A, Oriano M, Keir HR, Perea L, Canto E, Terranova L, Vidal S, Moffitt K, Aliberti S, Sibila O, Chalmers JD.

Eur Respir J. 2019 Jun 13;53(6). pii: 1900303. doi: 10.1183/13993003.00303-2019. Print 2019 Jun.

16.

A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults.

Crichton ML, Aliberti S, Chalmers JD.

Eur Respir Rev. 2019 Mar 14;28(151). pii: 180108. doi: 10.1183/16000617.0108-2018. Print 2019 Mar 31.

17.

National Survey on the Management of Adult Bronchiectasis in Belgium.

Schoovaerts K, Lorent N, Goeminne P, Aliberti S, Dupont L.

COPD. 2019 Feb;16(1):72-74. doi: 10.1080/15412555.2019.1566895. Epub 2019 Feb 21.

PMID:
30786778
18.

Comparison of different conditions for DNA extraction in sputum - a pilot study.

Oriano M, Terranova L, Teri A, Sottotetti S, Ruggiero L, Tafuro C, Marchisio P, Gramegna A, Amati F, Nava F, Franceschi E, Cariani L, Blasi F, Aliberti S.

Multidiscip Respir Med. 2019 Jan 31;14:6. doi: 10.1186/s40248-018-0166-z. eCollection 2019.

19.

Management of Acute Respiratory Failure Due to Community-Acquired Pneumonia: A Systematic Review.

Vanoni NM, Carugati M, Borsa N, Sotgiu G, Saderi L, Gori A, Mantero M, Aliberti S, Blasi F.

Med Sci (Basel). 2019 Jan 14;7(1). pii: E10. doi: 10.3390/medsci7010010. Review.

20.

A real life evaluation of non invasive ventilation in acute cardiogenic pulmonary edema: a multicenter, perspective, observational study for the ACPE SIMEU study group.

Aliberti S, Rosti VD, Travierso C, Brambilla AM, Piffer F, Petrelli G, Minelli C, Camisa D, Voza A, Guiotto G, Cosentini R; SIMEU ACPE study group.

BMC Emerg Med. 2018 Dec 29;18(1):61. doi: 10.1186/s12873-018-0216-z.

21.

Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective.

Gramegna A, Sotgiu G, Di Pasquale M, Radovanovic D, Terraneo S, Reyes LF, Vendrell E, Neves J, Menzella F, Blasi F, Aliberti S, Restrepo MI; GLIMP Study Group.

BMC Infect Dis. 2018 Dec 18;18(1):677. doi: 10.1186/s12879-018-3565-z.

22.

Non-invasive positive pressure ventilation in pneumonia outside Intensive Care Unit: An Italian multicenter observational study.

Brambilla AM, Prina E, Ferrari G, Bozzano V, Ferrari R, Groff P, Petrelli G, Scala R, Causin F, Noto P, Bresciani E, Voza A, Aliberti S, Cosentini R; 3P study group.

Eur J Intern Med. 2019 Jan;59:21-26. doi: 10.1016/j.ejim.2018.09.025. Epub 2018 Oct 25.

PMID:
30528840
23.

ERS syllabus for postgraduate training in respiratory infections: a guide for comprehensive training.

Aliberti S, Farr A, Tabin N, Blasi F, Torres A, Woodhead M, Migliori GB, Sotgiu G, Dimopoulos G, Chalmers JD, Ringshausen FC, Loebinger MR, Read R, Rohde G.

Breathe (Sheff). 2018 Dec;14(4):269-275. doi: 10.1183/20734735.026218.

24.

A comprehensive approach to lung function in bronchiectasis.

Radovanovic D, Santus P, Blasi F, Sotgiu G, D'Arcangelo F, Simonetta E, Contarini M, Franceschi E, Goeminne PC, Chalmers JD, Aliberti S.

Respir Med. 2018 Dec;145:120-129. doi: 10.1016/j.rmed.2018.10.031. Epub 2018 Nov 2.

PMID:
30509700
25.

The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) ERS Clinical Research Collaboration.

Aliberti S, Polverino E, Chalmers JD, Altenburg J, Shteinberg M, Goeminne PC, Welte T, Shoemark A, Almagro M, Blasi F; EMBARC Clinical Research Collaboration.

Eur Respir J. 2018 Nov 29;52(5). pii: 1802074. doi: 10.1183/13993003.02074-2018. Print 2018 Nov. No abstract available.

PMID:
30498055
26.

Flow cytometry identification of nonhemopoietic neoplasms during routine immunophenotyping.

Stacchini A, Aliberti S, Demurtas A, Maletta F, Molinaro L, Godio L, Papotti M.

Int J Lab Hematol. 2019 Apr;41(2):208-217. doi: 10.1111/ijlh.12946. Epub 2018 Nov 27.

PMID:
30480372
27.

Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study.

Carugati M, Aliberti S, Reyes LF, Franco Sadud R, Irfan M, Prat C, Soni NJ, Faverio P, Gori A, Blasi F, Restrepo MI.

ERJ Open Res. 2018 Oct 8;4(4). pii: 00096-2018. doi: 10.1183/23120541.00096-2018. eCollection 2018 Oct.

28.

Pneumonia is a neglected problem: it is now time to act.

Aliberti S, Dela Cruz CS, Sotgiu G, Restrepo MI.

Lancet Respir Med. 2019 Jan;7(1):10-11. doi: 10.1016/S2213-2600(18)30470-3. Epub 2018 Nov 12. No abstract available.

PMID:
30442586
29.

An international perspective on hospitalized patients with viral community-acquired pneumonia.

Radovanovic D, Sotgiu G, Jankovic M, Mahesh PA, Marcos PJ, Abdalla MI, Di Pasquale MF, Gramegna A, Terraneo S, Blasi F, Santus P, Aliberti S, Reyes LF, Restrepo MI; GLIMP Study Group.

Eur J Intern Med. 2019 Feb;60:54-70. doi: 10.1016/j.ejim.2018.10.020. Epub 2018 Nov 4.

30.

Research Needs on Respiratory Health in Migrant and Refugee Populations. An Official American Thoracic Society and European Respiratory Society Workshop Report.

Roman J, Viegi G, Schenker M, Ojeda VD, Pérez-Stable EJ, Nemery B, Annesi-Maesano I, Patel SR, La Grutta S, Holguin F, Moughrabieh A, Bime C, Lindberg A, Migliori GB, de Vries G, Ramírez J, Aliberti S, Feldman C, Celedón JC.

Ann Am Thorac Soc. 2018 Nov;15(11):1247-1255. doi: 10.1513/AnnalsATS.201807-478ST.

PMID:
30382778
31.

Failure to conceive in women with CF is associated with pancreatic insufficiency and advancing age.

Shteinberg M, Lulu AB, Downey DG, Blumenfeld Z, Rousset-Jablonski C, Perceval M, Colombo A, Stein N, Livnat G, Gur M, Bentur L, Mussaffi H, Blau H, Sarouk I, Dagan A, Kerem E, Aviram M, Picard E, Aliberti S, Álvarez A, Miranda JP, Polverino E, Durieu I, Stuart Elborn J, Cohen-Cymberknoh M.

J Cyst Fibros. 2019 Jul;18(4):525-529. doi: 10.1016/j.jcf.2018.10.009. Epub 2018 Oct 23.

PMID:
30366850
32.

Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis.

Sotgiu G, Aliberti S, Gramegna A, Mantero M, Di Pasquale M, Trogu F, Saderi L, Blasi F.

Respir Res. 2018 Oct 23;19(1):205. doi: 10.1186/s12931-018-0905-x.

33.

How to Process Sputum Samples and Extract Bacterial DNA for Microbiota Analysis.

Terranova L, Oriano M, Teri A, Ruggiero L, Tafuro C, Marchisio P, Gramegna A, Contarini M, Franceschi E, Sottotetti S, Cariani L, Bevivino A, Chalmers JD, Aliberti S, Blasi F.

Int J Mol Sci. 2018 Oct 20;19(10). pii: E3256. doi: 10.3390/ijms19103256.

34.

Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement.

Gramegna A, Aliberti S, Confalonieri M, Corsico A, Richeldi L, Vancheri C, Blasi F.

Multidiscip Respir Med. 2018 Oct 8;13:39. doi: 10.1186/s40248-018-0153-4. eCollection 2018.

35.

In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm.

Pollini S, Di Pilato V, Landini G, Di Maggio T, Cannatelli A, Sottotetti S, Cariani L, Aliberti S, Blasi F, Sergio F, Rossolini GM, Pallecchi L.

PLoS One. 2018 Oct 1;13(10):e0203941. doi: 10.1371/journal.pone.0203941. eCollection 2018.

36.

Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group.

Grignani G, D'Ambrosio L, Pignochino Y, Palmerini E, Zucchetti M, Boccone P, Aliberti S, Stacchiotti S, Bertulli R, Piana R, Miano S, Tolomeo F, Chiabotto G, Sangiolo D, Pisacane A, Dei Tos AP, Novara L, Bartolini A, Marchesi E, D'Incalci M, Bardelli A, Picci P, Ferrari S, Aglietta M.

Lancet Oncol. 2018 Oct;19(10):1360-1371. doi: 10.1016/S1470-2045(18)30438-8. Epub 2018 Sep 11.

PMID:
30217671
37.

The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: the study protocol.

Aliberti S, Codecasa LR, Gori A, Sotgiu G, Spotti M, Di Biagio A, Calcagno A, Nardini S, Assael BM, Tortoli E, Besozzi G, Ferrarese M, Matteelli A, Girardi E, De Lorenzo S, Seia M, Gramegna A, Del Prato B, Terranova L, Oriano M, Sverzellati N, Mirsaeidi M, Chalmers JD, Haworth CS, Loebinger MR, Aksamit T, Winthrop K, Ringshausen FC, Previdi G, Blasi F; IRENE Network.

Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):33. doi: 10.1186/s40248-018-0141-8. eCollection 2018.

38.

When and how ruling out cystic fibrosis in adult patients with bronchiectasis.

Gramegna A, Aliberti S, Seia M, Porcaro L, Bianchi V, Castellani C, Melotti P, Sorio C, Consalvo E, Franceschi E, Amati F, Contarini M, Gaffuri M, Roncoroni L, Vigone B, Bellofiore A, Del Monaco C, Oriano M, Terranova L, Patria MF, Marchisio P, Assael BM, Blasi F.

Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):29. doi: 10.1186/s40248-018-0142-7. eCollection 2018. Review.

39.

Get together to increase awareness in bronchiectasis: a report of the 2nd World Bronchiectasis Conference.

Aliberti S, Chalmers JD.

Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):28. doi: 10.1186/s40248-018-0138-3. eCollection 2018. No abstract available.

40.

Why, when and how to investigate primary ciliary dyskinesia in adult patients with bronchiectasis.

Contarini M, Shoemark A, Rademacher J, Finch S, Gramegna A, Gaffuri M, Roncoroni L, Seia M, Ringshausen FC, Welte T, Blasi F, Aliberti S, Chalmers JD.

Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):26. doi: 10.1186/s40248-018-0143-6. eCollection 2018. Review.

41.

Administrative databases and clinical governance: The case of COPD.

Pacileo G, Tozzi VD, Sotgiu G, Aliberti S, Morando V, Blasi F.

Int J Health Plann Manage. 2019 Jan;34(1):177-186. doi: 10.1002/hpm.2609. Epub 2018 Aug 16.

PMID:
30113709
42.

Knowledge and attitudes on influenza vaccination among Italian physicians specialized in respiratory infections: an Italian Respiratory Society (SIP/IRS) web-based survey.

Gramegna A, Dellafiore S, Contarini M, Blasi F, Aliberti S, Tosatto R, Mantero M.

J Prev Med Hyg. 2018 Jun 1;59(2):E128-E131. eCollection 2018 Jun. Erratum in: J Prev Med Hyg. 2018 Sep 28;59(3):E248.

43.

The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions.

Polverino E, Dimakou K, Hurst J, Martinez-Garcia MA, Miravitlles M, Paggiaro P, Shteinberg M, Aliberti S, Chalmers JD.

Eur Respir J. 2018 Sep 15;52(3). pii: 1800328. doi: 10.1183/13993003.00328-2018. Print 2018 Sep. Review.

PMID:
30049739
44.

Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients.

Restrepo MI, Babu BL, Reyes LF, Chalmers JD, Soni NJ, Sibila O, Faverio P, Cilloniz C, Rodriguez-Cintron W, Aliberti S; GLIMP.

Eur Respir J. 2018 Aug 9;52(2). pii: 1701190. doi: 10.1183/13993003.01190-2017. Print 2018 Aug.

45.

In vitro synergism of colistin in combination with N-acetylcysteine against Acinetobacter baumannii grown in planktonic phase and in biofilms.

Pollini S, Boncompagni S, Di Maggio T, Di Pilato V, Spanu T, Fiori B, Blasi F, Aliberti S, Sergio F, Rossolini GM, Pallecchi L.

J Antimicrob Chemother. 2018 Sep 1;73(9):2388-2395. doi: 10.1093/jac/dky185.

46.

ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update.

Migliori GB, Sotgiu G, Rosales-Klintz S, Centis R, D'Ambrosio L, Abubakar I, Bothamley G, Caminero JA, Cirillo DM, Dara M, de Vries G, Aliberti S, Dinh-Xuan AT, Duarte R, Midulla F, Solovic I, Subotic DR, Amicosante M, Correia AM, Cirule A, Gualano G, Kunst H, Palmieri F, Riekstina V, Tiberi S, Verduin R, van der Werf MJ.

Eur Respir J. 2018 May 17;51(5). pii: 1702678. doi: 10.1183/13993003.02678-2017. Print 2018 May.

47.

Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms.

Circosta P, Elia AR, Landra I, Machiorlatti R, Todaro M, Aliberti S, Brusa D, Deaglio S, Chiaretti S, Bruna R, Gottardi D, Massaia M, Giacomo FD, Guarini AR, Foà R, Kyriakides PW, Bareja R, Elemento O, Chichili GR, Monteleone E, Moore PA, Johnson S, Bonvini E, Cignetti A, Inghirami G.

Oncoimmunology. 2018 Feb 8;7(4):e1341032. doi: 10.1080/2162402X.2017.1341032. eCollection 2018.

48.

Nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae in an Italian university hospital: a molecular epidemiological study.

Sotgiu G, Are BM, Pesapane L, Palmieri A, Muresu N, Cossu A, Dettori M, Azara A, Mura II, Cocuzza C, Aliberti S, Piana A.

J Hosp Infect. 2018 Aug;99(4):413-418. doi: 10.1016/j.jhin.2018.03.033. Epub 2018 Apr 3.

PMID:
29621600
49.

Prognostic and Pathogenic Role of Angiopoietin-1 and -2 in Pneumonia.

Gutbier B, Neuhauß AK, Reppe K, Ehrler C, Santel A, Kaufmann J, Scholz M, Weissmann N, Morawietz L, Mitchell TJ, Aliberti S, Hippenstiel S, Suttorp N, Witzenrath M; CAPNETZ and PROGRESS Study Groups ‡.

Am J Respir Crit Care Med. 2018 Jul 15;198(2):220-231. doi: 10.1164/rccm.201708-1733OC.

PMID:
29447449
50.

Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: do we need a personalized approach?

Paolini V, Faverio P, Aliberti S, Messinesi G, Foti G, Sibila O, Monzani A, De Giacomi F, Stainer A, Pesci A.

PeerJ. 2018 Jan 30;6:e4211. doi: 10.7717/peerj.4211. eCollection 2018.

Supplemental Content

Loading ...
Support Center